Original Research
Published on 23 Sep 2022
Lymphocyte–C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.957407
- 3,881 views
- 23 citations



